Cargando…

A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD

The presence of advanced fibrosis is an important measure of the severity of chronic liver disease. Prior works that have examined the gut microbiome as a novel biomarker for advanced fibrosis have only examined patients with nonalcoholic fatty liver disease. Therefore, our goal was to examine the g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Tien S., Katzka, William, Lagishetty, Venu, Luu, Kayti, Hauer, Meg, Pisegna, Joseph, Jacobs, Jonathan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026172/ https://www.ncbi.nlm.nih.gov/pubmed/32066758 http://dx.doi.org/10.1038/s41598-020-59535-w

Ejemplares similares

The Ocular Microbiome Is Altered by Sampling Modality and Age
por: Katzka, William, et al.
Publicado: (2021)

Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease
por: Dong, Tien S., et al.
Publicado: (2021)

A High Protein Calorie Restriction Diet Alters the Gut Microbiome in Obesity
por: Dong, Tien S., et al.
Publicado: (2020)

The Intestinal Microbiome Predicts Weight Loss on a Calorie-Restricted Diet and Is Associated With Improved Hepatic Steatosis
por: Dong, Tien S., et al.
Publicado: (2021)

Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease
por: Dong, Tien S., et al.
Publicado: (2023)

Altered Gut Microbiome in Patients With Dermatomyositis
por: Bae, Sangmee Sharon, et al.
Publicado: (2022)

Fecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer
por: Luu, Kayti, et al.
Publicado: (2023)

Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
por: Jacobs, Jonathan P., et al.
Publicado: (2018)

Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys
por: Jasinska, Anna J., et al.
Publicado: (2020)

Microbial and Chemical Profiles of Commercial Kombucha Products
por: Yang, Jieping, et al.
Publicado: (2022)

Dietary Protein, Fiber and Coffee Are Associated with Small Intestine Microbiome Composition and Diversity in Patients with Liver Cirrhosis
por: Hussain, Shehnaz K., et al.
Publicado: (2020)

Obesity is associated with a distinct brain-gut microbiome signature that connects Prevotella and Bacteroides to the brain’s reward center
por: Dong, Tien S., et al.
Publicado: (2022)

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
por: Lee, Giljae, et al.
Publicado: (2020)

Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD
por: Sanchez, Jessica I., et al.
Publicado: (2023)

Microbiota-Dependent Upregulation of Bitter Taste Receptor Subtypes in the Mouse Large Intestine in High-Fat Diet-Induced Obesity
por: Caremoli, Filippo, et al.
Publicado: (2023)

Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD
por: Kang, Wonseok, et al.
Publicado: (2013)

Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts
por: Andréasson, Kristofer, et al.
Publicado: (2022)

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
por: Liebig, Stephanie, et al.
Publicado: (2019)

Microbial Metabolites: Critical Regulators in NAFLD
por: Dai, Xin, et al.
Publicado: (2020)

Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes
por: Jacobs, Jonathan P., et al.
Publicado: (2023)

Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)

Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis
por: Dong, Tien S., et al.
Publicado: (2021)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023)

Identified in blood diet-related methylation changes stratify liver biopsies of NAFLD patients according to fibrosis grade
por: Sokolowska, Katarzyna Ewa, et al.
Publicado: (2022)

Risk of severe illness of COVID‐19 patients with NAFLD and increased NAFLD fibrosis scores
por: Yao, Renling, et al.
Publicado: (2021)

A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones
por: Chou, Yu-Tsung, et al.
Publicado: (2021)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages
por: He, Weiwei, et al.
Publicado: (2023)

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
por: Bazick, Jessica, et al.
Publicado: (2015)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients
por: Neagoe, Carmen-Daniela, et al.
Publicado: (2020)

TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population
por: Martínez-Escudé, Alba, et al.
Publicado: (2021)

Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
por: Bernstein, David, et al.
Publicado: (2022)

Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD
por: Vieira Barbosa, Joana, et al.
Publicado: (2021)

Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD
por: Busca, C., et al.
Publicado: (2022)

Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score
por: Tapper, Elliot B., et al.
Publicado: (2016)

Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores
por: Noureddin, Mazen, et al.
Publicado: (2023)

Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
por: Pearce, Steven G, et al.
Publicado: (2013)

Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD
por: Sowa, Jan-Peter, et al.
Publicado: (2013)

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
por: Lee, Jenny, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n2nuof06n8gbsg0e5bbso9em6k